文献速递肝病

线粒体抗病毒信号蛋白通过ERK/TNFα/NFκβ通路促进MASLD进展

Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway.
PubMed 文献 · Hepatology · 2024-05-16

该研究通过小鼠肝脏蛋白质组学发现MAVS是p63下游靶点,并在动物模型和MASLD患者肝样本中验证MAVS表达诱导。遗传抑制MAVS可改善饮食诱导的MASLD,减少肝细胞脂质含量及TNFα、NFκβ表达,且MAVS的O-GlcNAcy化修饰是激活炎症和促进高脂含量的必要条件。

要点

  • MAVS在MASLD动物模型和患者肝脏中表达诱导,遗传敲低可改善饮食诱导的MASLD。
  • 沉默MAVS减弱油酸和棕榈酸诱导的脂质含量,过表达则增加肝细胞脂质负荷。
  • 抑制ERK可消除MAVS诱导的TNFα激活,MAVS的O-GlcNAcy化修饰是激活炎症所必需。

核心结论

  • MAVS参与脂肪变性发展,抑制已受损肝细胞中的MAVS可改善MASLD。

研究设计与样本

  • 对遗传操作肝脏p63的小鼠进行肝脏蛋白质组学分析,发现MAVS为p63下游靶点。
  • 在MASLD患者肝样本和动物模型中进一步评估MAVS,并在肝细胞系、原代肝细胞、球状体和鼠中进行MAVS遗传抑制。

主要发现

  • 与无肝病者相比,MAVS在MASLD动物模型和患者肝脏中表达诱导。
  • 在成年鼠中遗传敲低MAVS可改善饮食诱导的MASLD。
  • 体外沉默MAVS减弱油酸和棕榈酸诱导的脂质含量,过表达则增加肝细胞脂质负荷。
  • 抑制肝脏MAVS降低循环促炎细胞因子TNFα水平及肝脏TNFα和NFκβ表达。
  • 抑制ERK可消除MAVS诱导的TNFα激活;MAVS的O-GlcNAcy化修饰是激活炎症和促进肝细胞高脂含量所必需。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Mitochondrial antiviral signaling protein (MAVS) is a critical regulator that activates the host's innate immunity against RNA viruses, and its signaling pathway has been linked to the secretion of proinflammatory cytokines. However, the actions of MAVS on inflammatory pathways during the development of metabolic dysfunction-associated steatotic liver disease (MASLD) have been little studied. APPROACH AND RESULTS: Liver proteomic analysis of mice with genetically manipulated hepatic p63, a transcription factor that induces liver steatosis, revealed MAVS as a target downstream of p63. MAVS was thus further evaluated in liver samples from patients and in animal models with MASLD. Genetic inhibition of MAVS was performed in hepatocyte cell lines, primary hepatocytes, spheroids, and mice. MAVS expression is induced in the liver of both animal models and people with MASLD as compared with those without liver disease. Using genetic knockdown of MAVS in adult mice ameliorates diet-induced MASLD. In vitro, silencing MAVS blunts oleic and palmitic acid-induced lipid content, while its overexpression increases the lipid load in hepatocytes. Inhibiting hepatic MAVS reduces circulating levels of the proinflammatory cytokine TNFα and the hepatic expression of both TNFα and NFκβ. Moreover, the inhibition of ERK abolished the activation of TNFα induced by MAVS. The posttranslational modification O -GlcNAcylation of MAVS is required to activate inflammation and to promote the high lipid content in hepatocytes. CONCLUSIONS: MAVS is involved in the development of steatosis, and its inhibition in previously damaged hepatocytes can ameliorate MASLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Nóvoa E, da Silva Lima N, Gonzalez-Rellan MJ, et al. Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway. Hepatology. 2024. PMID: 38761407. doi:10.1097/HEP.0000000000000930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。